Greenovation
Laufzeit: 01.01.2016 - 31.12.2018
imported
Kurzfassung
An open-Label, multi-center study to evaluate the Pharmacokinetics, pharmacodynamics and the safety of moss-aGal in patients with Fabry Disease
Laufzeit: 01.01.2016 - 31.12.2018
An open-Label, multi-center study to evaluate the Pharmacokinetics, pharmacodynamics and the safety of moss-aGal in patients with Fabry Disease